# Clinical Study to Assess the Long-term Effect of Pep2Dia® on Glucose Homeostasis in Prediabetic Subjects

> **NCT05391854** · NA · COMPLETED · sponsor: **Ingredia S.A.** · enrollment: 128 (actual)

## Conditions studied

- Prediabetic State

## Interventions

- **DIETARY_SUPPLEMENT:** Pep2dia
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05391854
- **Lead sponsor:** Ingredia S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-21
- **Primary completion:** 2023-05-05
- **Final completion:** 2023-06-20
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2023-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05391854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05391854, "Clinical Study to Assess the Long-term Effect of Pep2Dia® on Glucose Homeostasis in Prediabetic Subjects". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT05391854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*